Market Research Logo

Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review

Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – Analyst’s summarization of the company’s business strategy.
SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

THERAMetrics holding AG (THERAMetrics), formerly mondoBIOTECH Holding AG, is a contract research and development organization (CRO). It discovers drugs for the treatment of rare diseases. It offers contract research and development services to various biopharmaceutical companies. The company develops medicinal product candidates by redirecting existing drugs through its proprietary Search and Match methodology for the treatment of orphan diseases; and validating its medicinal product candidates. THERAMetrics has strategic partnerships and licensing agreements for the development of ready-for-license medicinal product candidates. It has licensing collaborations with companies such as 23andMe, Inc., Biogen Idec, InterMune and Lung Rx. The company operates along with its subsidiaries, namely, THERAMetrics Discovery AG; THERAMetrics laboratories AG; www.mondobiotech.com, Inc.; and Pierrel Research International AG and its subsidiaries; in Switzerland, Liechtenstein, Italy, Germany, the US, Russia, the UK, Bulgaria, Serbia, Romania and Poland. THERAMetrics is headquartered in Stans, Switzerland.

Therametrics holding AG Key Recent Developments

Sep 02, 2015: THERAMetrics holding and Accelovance sign Master Agreement for collaboration in the Clinical Research area
Aug 18, 2015: THERAMetrics and Grünenthal Sign Collaboration Agreement on the use of the DRR2.0 System Technology
Jul 14, 2015: European Patent Office grants patent for treatment of Idiopathic Pulmonary Fibrosis to THERAMetrics
May 14, 2015: THERAMetrics announces the results of its Annual General Meeting and the elections to the Board of Directors
Apr 13, 2015: THERAMetrics holding announces today its financial results for 2014

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Therametrics holding AG - Key Facts
Therametrics holding AG - Key Employees
Therametrics holding AG - Key Employee Biographies
Therametrics holding AG - Major Products and Services
Therametrics holding AG - History
Therametrics holding AG - Company Statement
Therametrics holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Therametrics holding AG - Business Description
Therametrics holding AG - Corporate Strategy
Therametrics holding AG - SWOT Analysis
SWOT Analysis - Overview
Therametrics holding AG - Strengths
Strength - Research and Development
Strength - Orphan Drug Designation
Strength - Proprietary Technologies
Therametrics holding AG - Weaknesses
Weakness - Decline in Financial Performance
Weakness - Decline in Revenue from Americas and Switzerland
Therametrics holding AG - Opportunities
Opportunity - Business Initiatives
Opportunity - Growing Aged Population
Opportunity - Marketing Initiatives
Therametrics holding AG - Threats
Threat - Competition and Technological Change
Threat - Uncertain R&D Outcomes
Threat - Government Regulations
Therametrics holding AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Therametrics holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Therametrics holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Therametrics holding AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 02, 2015: THERAMetrics holding and Accelovance sign Master Agreement for collaboration in the Clinical Research area
Aug 18, 2015: THERAMetrics and Grünenthal Sign Collaboration Agreement on the use of the DRR2.0 System Technology
Jul 14, 2015: European Patent Office grants patent for treatment of Idiopathic Pulmonary Fibrosis to THERAMetrics
May 14, 2015: THERAMetrics announces the results of its Annual General Meeting and the elections to the Board of Directors
Apr 13, 2015: THERAMetrics holding announces today its financial results for 2014
Feb 18, 2015: THERAMetrics holding presents its DRR2.0 tool at Life Sciences Israel 2015
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Therametrics holding AG, Key Facts
Therametrics holding AG, Key Employees
Therametrics holding AG, Key Employee Biographies
Therametrics holding AG, Major Products and Services
Therametrics holding AG, History
Therametrics holding AG, Subsidiaries
Therametrics holding AG, Key Competitors
Therametrics holding AG, Ratios based on current share price
Therametrics holding AG, Annual Ratios
Therametrics holding AG, Interim Ratios
Therametrics holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Therametrics holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Therametrics holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Therametrics holding AG, Performance Chart (2010 - 2014)
Therametrics holding AG, Ratio Charts
Therametrics holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Therametrics holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report